Ind-Swift Labs.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE915B01019
  • NSEID: INDSWFTLAB
  • BSEID: 532305
INR
113.34
5.93 (5.52%)
BSENSE

Jan 30

BSE+NSE Vol: 7.86 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
456.23
173.92
887.56
903.07
732.09
664.80
582.91
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
456.23
173.92
887.56
903.07
732.09
664.80
582.91
Raw Material Cost
197.53
66.49
456.81
499.21
387.77
344.11
303.33
Purchase of Finished goods
30.41
39.45
12.22
6.61
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-6.96
-8.64
-6.89
-12.66
-47.68
-15.12
-4.37
Employee Cost
100.75
41.55
113.56
100.25
87.41
78.94
75.04
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
0.01
0.02
0.00
0.01
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
125.25
63.26
134.17
144.11
144.89
115.68
102.02
Total Expenditure (Excl Depreciation)
446.98
202.10
709.88
737.54
572.39
523.62
476.03
Operating Profit (PBDIT) excl Other Income
9.25
-28.18
177.68
165.53
159.70
141.18
106.88
Other Income
60.02
40.78
20.11
23.29
21.51
20.13
22.36
Operating Profit (PBDIT)
69.27
12.60
197.79
188.82
181.21
161.31
129.24
Interest
3.84
10.61
62.57
70.34
72.04
75.91
84.57
Exceptional Items
-5.85
-0.73
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
59.58
1.26
135.22
118.48
109.17
85.40
44.67
Depreciation
22.49
6.28
40.63
48.08
49.23
59.36
67.69
Profit Before Tax
37.09
-5.02
94.59
70.40
59.93
26.05
-23.04
Tax
10.88
-0.92
25.84
-2.48
0.62
0.00
0.40
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
26.21
-4.09
68.76
72.88
59.30
26.05
-23.44
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
26.21
-4.09
68.76
72.88
59.30
26.05
-23.44
Share in Profit of Associates
0.09
-0.05
-0.44
-0.16
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
26.30
-4.14
68.32
72.72
59.30
26.05
-23.44
Equity Capital
81.61
59.09
59.09
59.09
59.09
59.09
47.57
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Diluted Earnings per share
1.13
-0.82
3.29
4.65
2.71
1.95
-1.9
Operating Profit Margin (Excl OI)
2.03%
-16.2%
20.02%
18.33%
21.81%
21.24%
18.34%
Gross Profit Margin
13.06%
0.72%
15.24%
13.12%
14.91%
12.85%
7.66%
PAT Margin
5.74%
-2.35%
7.75%
8.07%
8.1%
3.92%
-4.02%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2025 is 162.32% vs -80.40% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in nine months ended Dec 2025 is 735.27% vs -106.06% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2025 is 132.82% vs -115.86% in Dec 2024

stock-summary

Interest

YoY Growth in nine months ended Dec 2025 is -63.81% vs -83.04% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2025 has improved from Dec 2024

Compare Nine Monthly Results Of Ind-Swift Labs. With
Markets Mojo
Figures in Cr
Consolidate Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
456.23
0
456.23
Other Operating Income
0.00
0.00
0.00
Total Operating income
456.23
0
456.23
Raw Material Cost
197.53
0
197.53
Purchase of Finished goods
30.41
0
30.41
(Increase) / Decrease In Stocks
-6.96
0
-6.96
Employee Cost
100.75
0
100.75
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
125.25
0.00
125.25
Total Expenditure (Excl Depreciation)
446.98
0
446.98
Operating Profit (PBDIT) excl Other Income
9.25
0.00
9.25
Other Income
60.02
0
60.02
Operating Profit (PBDIT)
69.27
0
69.27
Interest
3.84
0
3.84
Exceptional Items
-5.85
0
-5.85
Gross Profit (PBDT)
59.58
0
59.58
Depreciation
22.49
0
22.49
Profit Before Tax
37.09
0
37.09
Tax
10.88
0
10.88
Provisions and contingencies
0.00
0
0.00
Profit After Tax
26.21
0
26.21
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
26.21
0
26.21
Share in Profit of Associates
0.09
0
0.09
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
26.30
0
26.30
Equity Capital
81.61
0
81.61
Face Value
10.00
0
0.00
Reserves
0.00
0
0.00
Gross Profit Margin
13.06%
0.00%
0.00
13.06%
PAT Margin
5.74%
0.00%
0.00
5.74%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 456.23 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 162.32% vs -80.40% in Dec 2024

Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 26.30 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 735.27% vs -106.06% in Dec 2024

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 9.25 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 132.82% vs -115.86% in Dec 2024

Nine Monthly - Interest
Interest 3.84 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is -63.81% vs -83.04% in Dec 2024

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 2.03%
in Dec 2025

Figures in %
stock-summary

YoY Growth in nine months ended Dec 2025 has improved from Dec 2024